Literature DB >> 21307135

Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolism.

Javier Delgado-Lista1, Antonio Garcia-Rios, Pablo Perez-Martinez, Juan Solivera, Elena M Yubero-Serrano, Francisco Fuentes, Laurence D Parnell, Jian Shen, Purificacion Gomez, Yolanda Jimenez-Gomez, Maria J Gomez-Luna, Carmen Marin, Sarah E Belisle, Fernando Rodriguez-Cantalejo, Simin N Meydani, Jose M Ordovas, Francisco Perez-Jimenez, Jose Lopez-Miranda.   

Abstract

CONTEXT: IL1b (IL1B or IL1β), a key modulator of the immune response, exerts its functions mainly via IL6 regulation. Fatty meals cause transient hypertriglyceridemia and are considered to be proinflammatory, but the extent of these responses shows high interindividual susceptibility.
OBJECTIVE: We evaluated the influence of a genetic variant located in the promoter region of IL1B (-1473G/C) on fasting and postprandial lipids and IL6. DESIGN, SETTING, AND PARTICIPANTS: A total of 477 people over age 65 yr were genotyped for IL1B -1473G/C, and we evaluated fasting lipids depending on genotype. Then, 88 healthy young men were also genotyped and were fed a saturated fatty acid-rich meal. Serial blood samples were drawn for 11 h after the meal, and lipid fractions and IL6 were assayed. MAIN OUTCOME AND
INTERVENTIONS: Fasting lipids were studied in the aged persons. Fasting and postprandial measurements of lipids and IL6 were performed in the healthy young men.
RESULTS: In the aged persons, CC subjects (minor allele homozygotes) showed higher triglyceride (P = 0.002) and cholesterol (P = 0.011) levels. Healthy young male carriers of the minor C allele showed higher postprandial triglycerides (P = 0.037), and those carried into large triglyceride-rich lipoproteins (P = 0.004). In addition, they showed higher postprandial IL6 concentrations (P = 0.008).
CONCLUSIONS: Our work shows that inflammatory genes may regulate fasting and postprandial lipids because the carriers of the minor allele of an IL gene variant have altered lipid metabolism. To reinforce these gene-phenotype findings, IL6 (the natural effector of IL1B) was increased in these persons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307135      PMCID: PMC3085209          DOI: 10.1210/jc.2010-2455

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

Review 1.  Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6.

Authors:  A Woods; D J Brull; S E Humphries; H E Montgomery
Journal:  Eur Heart J       Date:  2000-10       Impact factor: 29.983

Review 2.  Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease.

Authors:  José López-Miranda; Pablo Pérez-Martínez; Carmen Marín; Juan A Moreno; Purificación Gómez; Francisco Pérez-Jiménez
Journal:  Curr Opin Lipidol       Date:  2006-04       Impact factor: 4.776

Review 3.  Role of IL-1beta in type 2 diabetes.

Authors:  Charles A Dinarello; Marc Y Donath; Thomas Mandrup-Poulsen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-08       Impact factor: 3.243

4.  Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall.

Authors:  H G Rus; R Vlaicu; F Niculescu
Journal:  Atherosclerosis       Date:  1996-12-20       Impact factor: 5.162

5.  Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial.

Authors:  Simin Nikbin Meydani; Lynette S Leka; Basil C Fine; Gerard E Dallal; Gerald T Keusch; Maria Fiatarone Singh; Davidson H Hamer
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

Review 6.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.

Authors:  Weerapan Khovidhunkit; Min-Sun Kim; Riaz A Memon; Judy K Shigenaga; Arthur H Moser; Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2004-04-21       Impact factor: 5.922

7.  Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population.

Authors:  Kyung-A Lee; Chang-Seok Ki; Hye-Jin Kim; Kwang-Min Sohn; Jong-Won Kim; Won Ki Kang; Jong Chul Rhee; Sang Yong Song; Tae Sung Sohn
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

Review 8.  Inflammatory bio-markers and cardiovascular risk prediction.

Authors:  G J Blake; P M Ridker
Journal:  J Intern Med       Date:  2002-10       Impact factor: 8.989

9.  Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome.

Authors:  Jian Shen; Donna K Arnett; James M Peacock; Laurence D Parnell; Aldi Kraja; James E Hixson; Michael Y Tsai; Chao-Qiang Lai; Edmond K Kabagambe; Robert J Straka; Jose M Ordovas
Journal:  J Nutr       Date:  2007-08       Impact factor: 4.798

10.  Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro.

Authors:  L Iacoviello; A Di Castelnuovo; M Gattone; A Pezzini; D Assanelli; R Lorenzet; E Del Zotto; M Colombo; E Napoleone; C Amore; A D'Orazio; A Padovani; G de Gaetano; P Giannuzzi; M B Donati
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-11-11       Impact factor: 8.311

View more
  11 in total

1.  More than inflammation: interleukin-1beta polymorphisms and the lipid metabolism.

Authors:  Mihai G Netea; Charles A Dinarello
Journal:  J Clin Endocrinol Metab       Date:  2011-05       Impact factor: 5.958

2.  Cytokine Gene Polymorphisms Associated With Various Domains of Quality of Life in Women With Breast Cancer.

Authors:  Kimberly Alexander; Yvette P Conley; Jon D Levine; Bruce A Cooper; Steven M Paul; Judy Mastick; Claudia West; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-09-23       Impact factor: 3.612

3.  Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion.

Authors:  Janna A van Diepen; Rinke Stienstra; Irene O C M Vroegrijk; Sjoerd A A van den Berg; Daniela Salvatori; Guido J Hooiveld; Sander Kersten; Cees J Tack; Mihai G Netea; Johannes W A Smit; Leo A B Joosten; Louis M Havekes; Ko Willems van Dijk; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2012-11-17       Impact factor: 5.922

Review 4.  Magnitude and Timing of the Postprandial Inflammatory Response to a High-Fat Meal in Healthy Adults: A Systematic Review.

Authors:  Sam R Emerson; Stephanie P Kurti; Craig A Harms; Mark D Haub; Tonatiuh Melgarejo; Cindy Logan; Sara K Rosenkranz
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

5.  Genetic variation in Tanis was associated with elevating plasma triglyceride level in Chinese nondiabetic subjects.

Authors:  Ying Gao; Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Xiao-Mei Li; Zhen-Yan Fu; Ying-Ying Zheng; Xiang Ma; Bang-Dang Chen; Fen Liu; Ying Huang
Journal:  Lipids Health Dis       Date:  2013-07-05       Impact factor: 3.876

6.  Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease.

Authors:  Xi Chen; Zhen-Wen Zhao; Lin Li; Xue-Jun Chen; Hui Xu; Jin-Tu Lou; Lin-Jie Li; Li-Zhong Du; Chun-Hong Xie
Journal:  Lipids Health Dis       Date:  2015-12-30       Impact factor: 3.876

7.  Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout.

Authors:  Cushla McKinney; Lisa K Stamp; Nicola Dalbeth; Ruth K Topless; Richard O Day; Diluk Rw Kannangara; Kenneth M Williams; Matthijs Janssen; Timothy L Jansen; Leo A Joosten; Timothy R Radstake; Philip L Riches; Anne-Kathrin Tausche; Frederic Lioté; Alexander So; Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2015-10-13       Impact factor: 5.156

8.  Quantile-dependent expressivity of postprandial lipemia.

Authors:  Paul T Williams
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

9.  Effects of rs7903146 variation in the Tcf7l2 gene in the lipid metabolism of three different populations.

Authors:  Pablo Perez-Martinez; Ana I Perez-Caballero; Antonio Garcia-Rios; Elena M Yubero-Serrano; Antonio Camargo; Maria J Gomez-Luna; Carmen Marin; Purificacion Gomez-Luna; Aldona Dembinska-Kiec; Fernando Rodriguez-Cantalejo; Francisco J Tinahones; Helen M Roche; Francisco Perez-Jimenez; Jose Lopez-Miranda; Javier Delgado-Lista
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.

Authors:  You Yin; Yan Liu; Xiao Pan; Rui Chen; Peng Li; Hui-Juan Wu; Zheng-Qing Zhao; Yan-Peng Li; Liu-Qing Huang; Jian-Hua Zhuang; Zhong-Xin Zhao
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.